Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Monica You"'
Autor:
Ken Flanagan, Kent Fitzgerald, Jeanne Baker, Karin Regnstrom, Shyra Gardai, Frederique Bard, Simonetta Mocci, Pui Seto, Monica You, Catherine Larochelle, Alexandre Prat, Samuel Chow, Lauri Li, Chris Vandevert, Wagner Zago, Carlos Lorenzana, Christopher Nishioka, Jennifer Hoffman, Raquel Botelho, Christopher Willits, Kevin Tanaka, Jennifer Johnston, Ted Yednock
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40443 (2012)
TH17 cells enter tissues to facilitate pathogenic autoimmune responses, including multiple sclerosis (MS). However, the adhesion molecules involved in the unique migratory capacity of TH17 cells, into both inflamed and uninflamed tissues remain uncle
Externí odkaz:
https://doaj.org/article/ce9517ea747141bb9e840827a0281c34
Autor:
Philip Vitorino, Alexander J. Bankovich, Monette Aujay, Zhaomei Zhang, Angeline T. Dang, Christina Lee, Dorothy French, Theodore Sullivan, Kumiko Isse, Monica You, Christine Gu, Marybeth Pysz, Hetal Sarvaiya, Xi Zhao, Alexander Schammel, Julia Gavrilyuk, Wolf R. Wiedemeyer
Supplementary Figure from ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e04dfbdd6edb05fe4f748df6a64c4e
https://doi.org/10.1158/1535-7163.22522480.v1
https://doi.org/10.1158/1535-7163.22522480.v1
Autor:
Philip Vitorino, Alexander J. Bankovich, Monette Aujay, Zhaomei Zhang, Angeline T. Dang, Christina Lee, Dorothy French, Theodore Sullivan, Kumiko Isse, Monica You, Christine Gu, Marybeth Pysz, Hetal Sarvaiya, Xi Zhao, Alexander Schammel, Julia Gavrilyuk, Wolf R. Wiedemeyer
In the past year, four antibody–drug conjugates (ADC) were approved, nearly doubling the marketed ADCs in oncology. Among other attributes, successful ADCs optimize targeting antibody, conjugation chemistry, and payload mechanism of action. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747b7f4105aad333d4f4a606f7dcdc81
https://doi.org/10.1158/1535-7163.c.6543391.v1
https://doi.org/10.1158/1535-7163.c.6543391.v1
Autor:
Wolf R. Wiedemeyer, Julia Gavrilyuk, Alexander Schammel, Xi Zhao, Hetal Sarvaiya, Marybeth Pysz, Christine Gu, Monica You, Kumiko Isse, Theodore Sullivan, Dorothy French, Christina Lee, Angeline T. Dang, Zhaomei Zhang, Monette Aujay, Alexander J. Bankovich, Philip Vitorino
Publikováno v:
Molecular cancer therapeutics. 21(6)
In the past year, four antibody–drug conjugates (ADC) were approved, nearly doubling the marketed ADCs in oncology. Among other attributes, successful ADCs optimize targeting antibody, conjugation chemistry, and payload mechanism of action. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f8b709d8d4cf012763410968de952c
https://pubmed.ncbi.nlm.nih.gov/35642431
https://pubmed.ncbi.nlm.nih.gov/35642431
Autor:
Jing Zhang, Wenhua Shi, Min Chen, Xinchuan Dai, Hongshui Liu, Shou Li, Lina Wang, Bee-Chun Sun, Monica You, Vivian Morton, Qiuping Ye, Lishan Kang, Bing Wan, Peter Brams, David I. Bellovin
Publikováno v:
Cancer Research. 82:3590-3590
Despite the promise of immunotherapy for cancer treatment, nearly 80% of patients fail to respond to checkpoint inhibitor (CPI) therapy. Regulatory T cells (Tregs), which inhibit immune responses in the tumor microenvironment via multiple suppressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a765a1cb55f1e9c9fff451096351b7a8
https://doi.org/10.1158/1538-7445.am2022-3590
https://doi.org/10.1158/1538-7445.am2022-3590
Autor:
Juan Jose Fung, Ryan Stafford, Gang Yin, Chris Murray, Xiaofan Li, Marissa L. Matsumoto, Alex Steiner, Ramesh Baliga, Trevor J. Hallam, Heather Stephenson, Qi Cai, Christopher D. Thanos, Willie D. Wang, Mary Rose Masikat, Monica You, Avinash Gill, Aaron K. Sato, Shwu-Hwa Lin, Kalyani Penta
Publikováno v:
Protein Engineering, Design and Selection
Selection technologies such as ribosome display enable the rapid discovery of novel antibody fragments entirely in vitro. It has been assumed that the open nature of the cell-free reactions used in these technologies limits selections to single-chain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60af782707d4cb2bc70aeb4f30e0a1c
https://doi.org/10.1093/protein/gzu002
https://doi.org/10.1093/protein/gzu002
Autor:
Kevin Tanaka, Marcelle Bergeron, Donald J. Fauss, Maria Armanda Viana Rodrigues, Jeanne Baker, Yangli Yang, Pui Seto, Monica You, Linnea Diep, Ruth Motter, Lilibeth Dofiles
Publikováno v:
Journal of Neuroscience Methods. 215:245-257
Tyrosine hydroxylase (TH) catalyses the rate-limiting step in the biosynthesis of catecholamines. TH expression is regulated in a tissue-specific manner during neuronal development and differentiation. Because of its key regulatory role in central an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5158819f7abe898c2b26ab09be64b0
https://doi.org/10.1016/j.jneumeth.2013.03.012
https://doi.org/10.1016/j.jneumeth.2013.03.012
Autor:
Jae-Im Kwon, Hwon Heo, Yeon Ji Chae, Joongkee Min, Do-Wan Lee, Sang Tae Kim, Monica Young Choi, Yu Sub Sung, Kyung Won Kim, Yoonseok Choi, Dong Cheol Woo, Chul-Woong Woo
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15596- (2023)
Aryl hydrocarbon receptors (AhRs) have been reported to be important mediators of ischemic injury in the brain. Furthermore, the pharmacological inhibition of AhR activation after ischemia has been shown to attenuate cerebral ischemia-reperfusion (IR
Externí odkaz:
https://doaj.org/article/53adcb21936b45fd87c3b4888542de0e
Autor:
Youngmin Ko, Yu-Mee Wee, Sung Shin, Mi Joung Kim, Monica Young Choi, Dong Hyun Kim, Seong Jun Lim, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Duck Jong Han
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Background The optimal dose of anti-thymocyte globulin (ATG) as an induction regimen in Asian living-donor kidney recipients is unclear. Methods This is a pilot study in which 36 consecutive patients undergoing living-donor kidney transplantation wer
Externí odkaz:
https://doaj.org/article/0a8cc9922afb420ab16f30fc2665dd3d
Autor:
Lauri Li, Carlos Lorenzana, Ken Flanagan, Alexandre Prat, Simonetta Mocci, Raquel Botelho, Christopher Nishioka, Frederique Bard, Jennifer Hoffman, Kent Fitzgerald, Shyra J. Gardai, Jeanne Baker, Karin Regnstrom, Christopher Willits, Ted Yednock, Pui Seto, Monica You, Chris Vandevert, Catherine Larochelle, Jennifer Johnston, Samuel Chow, Wagner Zago, Kevin Tanaka
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e40443 (2012)
PLoS ONE, Vol 7, Iss 7, p e40443 (2012)
TH17 cells enter tissues to facilitate pathogenic autoimmune responses, including multiple sclerosis (MS). However, the adhesion molecules involved in the unique migratory capacity of TH17 cells, into both inflamed and uninflamed tissues remain uncle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eef2665c296afb646678f72ef150da1
https://doi.org/10.1371/journal.pone.0040443
https://doi.org/10.1371/journal.pone.0040443